Chromadex Corp

General ticker "CDXC" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $512.6M

Chromadex Corp follows the US Stock Market performance with the rate: 47.8%.

Estimated limits based on current volatility of 2.8%: low 5.31$, high 5.61$

Factors to consider:

  • Current price 89.9% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.30$, 2.79$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.58$, 3.24$]

Financial Metrics affecting the CDXC estimates:

  • Negative: Non-GAAP EPS, $ of -0.07 <= 0.10
  • Negative: Operating profit margin, % of -6.28 <= 1.03
  • Positive: 2.35 < Operating cash flow per share per price, % of 6.80
  • Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
  • Positive: Inventory ratio change, % of -2.14 <= -1.03

Similar symbols

Short-term CDXC quotes

Long-term CDXC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $67.45MM $72.05MM $83.57MM
Operating Expenses $94.52MM $90.68MM $89.17MM
Operating Income $-27.07MM $-18.63MM $-5.60MM
Non-Operating Income $-0.06MM $2.09MM $0.66MM
Interest Expense $0.06MM $0.00MM $0.00MM
R&D Expense $3.83MM $4.83MM $4.96MM
Income(Loss) $-27.13MM $-16.54MM $-4.94MM
Profit(Loss) $-27.13MM $-16.54MM $-4.94MM
Stockholders Equity $31.73MM $28.67MM $28.46MM
Inventory $13.60MM $14.68MM $14.53MM
Assets $57.84MM $54.06MM $54.96MM
Operating Cash Flow $-24.16MM $-15.10MM $7.12MM
Capital expenditure $0.41MM $0.33MM $0.15MM
Investing Cash Flow $-0.41MM $-0.33MM $-0.14MM
Financing Cash Flow $36.09MM $7.65MM $-0.09MM
Earnings Per Share* $-0.38 $-0.21 $-0.07

* EPS are Split Adjusted, recent splits may be reflected with a delay.